7th Edition of Neurology World Conference 2027

Neuromodulation is changing what is possible for patients who have run out of options. By delivering carefully controlled electrical or magnetic pulses to the nervous system, these therapies can reduce seizures, ease chronic pain, quiet tremor, and lift depression in people who have not responded to medicines.

This track covers technologies currently in clinical use, including deep brain stimulation (DBS), transcranial magnetic stimulation (TMS), vagus nerve stimulation (VNS), and spinal cord stimulation (SCS). It looks at both the devices themselves and their use in conditions such as Parkinson's disease, essential tremor, dystonia, neuropathic pain, epilepsy, and urinary incontinence.

Neurologists, neurosurgeons, researchers, and medical device companies are welcome. Share your patient outcomes, case studies, programming strategies, and the problems you are still working to solve.

Topics include:

• Deep brain stimulation for movement and psychiatric disorders
• Transcranial magnetic and direct current stimulation
• Vagus nerve and spinal cord stimulation
• Responsive neurostimulation for epilepsy
• Wearable and home-based neurotechnology
• Patient selection, safety, and ethics

Join us to explore how neuromodulation is opening new doors in neurological care.